Sartorius AG (XSWX:SRT3) SpecialCharges


XSWX:SRT3 Sartorius AG XSWX:SRT3
82 GF Score
Price CHF207.80
GF Value CHF228.12
! 9 Warning Signs
View Full Analysis

What is Sartorius AG SpecialCharges?

Special Charges only applies to banks.

XSWX:SRT3
82GF Score
Sartorius AG XSWX:SRT3
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sartorius AG (XSWX:SRT3) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius AG stock appears to be undervalued. The current stock price of CHF207.80 is trading 8.9% below its estimated GF Value™ of CHF228.12.

Key valuation signals for XSWX:SRT3:

  • SpecialCharges:
  • GF Value™: CHF228.12 vs. price of CHF207.80 (8.9% below fair value)
  • GF Score™: 82/100 with 9 warning signs

No single metric tells the full story. See the XSWX:SRT3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sartorius AG Business Description

Address Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
82GF Score

Get the complete analysis for XSWX:SRT3

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF207.80
Price
CHF228.12
GF Value